Targeted Therapy Technologies, LLC

3972 Barranca Pkwy Ste J185, Irvine, California, United States

Also known as:

3 t ophthalmics

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

80.0%

Phase 2

20.0%

Trial Status Distribution

Active, not recruiting

80.0%

Recruiting

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Retinoblastoma Phase II Expanded Access Clinical Trial

Phase 2

Recruiting

interventional

Feb 202530 participants

Topotecan Episcleral Plaque for Treatment of Retinoblastoma

Phase 1

Active, not recruiting

interventional

Jun 202142 participants

Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Phase 1

Active, not recruiting

interventional

Mar 20213 participants

Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Phase 1

Active, not recruiting

interventional

Sep 20192 participants

A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema

Phase 1

Active, not recruiting

interventional

Apr 20191 participant

Approvals

No approval data available

News

No news articles found

Back to Organizations